RMD · 8-K · 20260806PR337962

Operating Margin Drivers

RESMED INC · 2026-08-06 · Importance 47 · Surprise 22 · From source text

Fiscal-year GAAP income from operations increased 12% to $1,886.7 million, and GAAP operating margin expanded 70 basis points to 33.4%. Fiscal-year non-GAAP operating income increased 16% to $2,039.1 million, with non-GAAP operating margin expanding 180 basis points to 36.1%. Fourth-quarter GAAP operating income declined 1% to $448.7 million and GAAP operating margin fell 300 basis points to 30.7%, reflecting the $41.9 million Astral field safety notification expense. Fourth-quarter non-GAAP operating income increased 8% to $515.0 million, while non-GAAP diluted EPS increased 16% to $2.95.

Key facts

• Net income for twelve months ended June 30, 2026: $1,523,293 thousand vs $1,400,723 thousand prior year source
• Q4 non-GAAP income from operations: $515 million vs $476 million prior year, an 8% increase (three months ended) source
• GAAP income from operations for Q4: $448,708 thousand vs $454,543 thousand prior year (three months ended) source
• Q4 GAAP diluted earnings per share: $2.64, up 2% source
• Q4 non-GAAP diluted earnings per share: $2.95, up 16% source
• FY 2026 GAAP operating margin was 33.4%, up 70 basis points source
• FY 2026 non-GAAP operating margin was 36.1%, up 180 basis points source
• FY 2026 non-GAAP diluted earnings per share: $11.17, an increase of 17% source

Impact estimates